SEC Form 3 · accession 0001193125-26-394320
Avalyn Pharma Inc. · AVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Meyer
Director
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001540171
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24 - Power of Attorney